Skip to main content
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: Human laboratory findings
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161630/No data is associated with this publication.
Abstract
Rationale: Heavy-drinking smokers constitute a sizeable and hard-to-treat subgroup of smokers, for whom tailored smoking cessation therapies are not yet available.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.